🇺🇸 FDA
Patent

US 8426365

Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure

granted A61KA61K31/21A61K38/2292

Quick answer

US patent 8426365 (Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure) held by REGENERX BIOPHARMACEUTICALS, INC. expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERX BIOPHARMACEUTICALS, INC.
Grant date
Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/21, A61K38/2292, A61P, A61P9/00